Morgan Stanley Maintains Equal-Weight on Outset Medical, Raises Price Target to $5.5
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Drew Ranieri has maintained an Equal-Weight rating on Outset Medical (NASDAQ: OM) and increased the price target from $5 to $5.5.
December 04, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Outset Medical's price target has been raised from $5 to $5.5 by Morgan Stanley, while maintaining an Equal-Weight rating.
The increase in price target by a reputable analyst like Drew Ranieri from Morgan Stanley can be seen as a positive signal for investors, suggesting a potential upside for the stock. However, since the rating remains Equal-Weight, the impact might be moderate rather than strong.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100